Grape King Bio Ltd Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Grape King Bio Ltd Stock Forecast and Price Target
Grape King Bio Ltd's stock is projected to advance by 6.71% from the previous closing price if it reaches the average target of NT$167.00 by the year's end, as three reputable analysts recently projected. This potential upside is calculated on a high-end estimate of NT$196.00 and a low-end estimate of NT$161.00. Even if you are not interested in 1707 stock, it is still crucial to be aware of its competitors.
6.71% Upside
Grape King Bio Ltd Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Grape King Bio Ltd's Price has gone down from NT$162.76 to NT$0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach NT$190.44 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4128 Stock Forecast | Microbio | - |
8
|
NT$41.80 | Buy/Sell | NT$24.84 | -100.00% |
| 4746 Stock Forecast | Formosa Laboratories | Buy |
12
|
NT$101.00 | Buy/Sell | NT$143.00 | 36.14% |
| 1720 Stock Forecast | Standard Chemical & Pharmaceut... | - |
18
|
NT$63.40 | Buy/Sell | NT$0.00 | -100.00% |
| 4167 Stock Forecast | Savior Lifetec | - |
13
|
NT$21.40 | Buy/Sell | NT$23.74 | -100.00% |
| 1777 Stock Forecast | SYN-TECH Chem. & Pharm. | - |
16
|
NT$84.30 | Buy/Sell | NT$87.00 | -100.00% |
Grape King Bio Ltd Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Grape King Bio Ltd's Revenue has grown, rising from NT$9.17B to NT$10.64B – a growth of 16.00%. In the next year, analysts believe that Revenue will reach NT$11.79B – an increase of 10.88%. For the next seven years, the forecast is for Revenue to grow by 10.37%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4155 Stock Forecast | OK Biotech | - |
0
|
NT$26.80 | Buy/Sell | NT$25.41 | -100.00% |
| 1780 Stock Forecast | Allied Biotech | - |
0
|
NT$17.70 | Buy/Sell | NT$0.00 | -100.00% |
| 4102 Stock Forecast | Yung Zip Chemical Ind. | - |
3
|
NT$40.00 | Buy/Sell | NT$0.00 | -100.00% |
.jpg)
Grape King Bio Ltd Dividend per Share Forecast for 2023 - 2025 - 2030
Grape King Bio Ltd's Dividend per Share has grown In the last three years, rising from NT$6.40 to NT$6.90 – a growth of 7.81%. In the next year, analysts believe that Dividend per Share will reach NT$7.33 – an increase of 6.23%. For the next seven years, experts predict that Grape King Bio Ltd's Dividend per Share will grow at a rate of 9.02%.
Grape King Bio Ltd EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Grape King Bio Ltd's EBITDA has grown by 8.56%, rising from NT$2.66B to NT$2.88B. For the next year, analysts predict that EBITDA will reach NT$3.28B – an increase of 13.63%. Over the next seven years, experts believe that Grape King Bio Ltd's EBITDA will grow at a rate of 14.70%.
Grape King Bio Ltd EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Grape King Bio Ltd's EBIT has grown, moving from NT$2.30B to NT$2.50B – an increase of 8.33%. In the next year, analysts predict that EBIT will jump to NT$2.81B – up 12.49% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 12.41%.
Grape King Bio Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Grape King Bio Ltd's EPS has gone down from NT$9.29 to NT$0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach NT$10.87 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)